Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Pressure BioSciences announces presentations on advantages of PCT

Pressure BioSciences, Inc. today announced that five presentations on the advantages of pressure cycling technology (PCT) in the preparation, processing, identification, and quantification of proteins were made at last week's annual meeting of US HUPO (Human Proteomics Organization) in Denver, Colorado.

From Thermo Fisher Scientific Inc. 19 Mar 2010

Activeion Cleaning Solutions announces new European subsidiary, Activeion GmbH

Activeion Cleaning Solutions LLC, Rogers, MN USA is proud to announce its new European subsidiary, Activeion (Europe) GmbH. Activeion (Europe) GmbH will distribute and market the ionator EXP™ throughout Europe, the Middle East and Africa. Activeion's ionator EXP™ is a handheld, on-demand, completely chemical-free cleaning tool that activates and converts tap water into ionised water, a powerful dirt-removing and bacteria-killing product.

19 Mar 2010

Propeller tears right arm, UT Southwestern Medical Center surgeon re-attaches

"The propeller cut through the skin, muscle, tendons and bone and had removed portions of the bone," he recalled. "Basically, she had severed her arm, and it was attached only by some skin, tendon, nerve and artery."

19 Mar 2010

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

OSI Pharmaceuticals, Inc. announced today that its international partner for Tarceva® (erlotinib), Roche, informed OSI that the European Committee for Medicinal Products for Human Use has issued a positive opinion recommending approval of Tarceva as monotherapy for maintenance treatment in patients with locally advanced or metastatic non-small cell lung cancer with stable disease following four cycles of standard platinum-based first-line chemotherapy.

19 Mar 2010

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Scientists report a protein made by a gene already associated with a handful of human inflammatory immune diseases plays a pivotal role in protecting the intestinal tract from colitis.

19 Mar 2010

Implementation of evidenced-based practices reduces all healthcare-associated MRSA infections

Scientists at The Virginia Commonwealth University Medical Center found that an emphasis on compliance with non-pathogen specific infection control practices such as hand hygiene, efforts to reduce device-related infections and chlorhexidine bathing (a daily bath with the same antibacterial agent used by surgeons to "scrub in" before an operation), is successful in reducing rates of healthcare-associated methicillin-resistant Staphylococcus aureus.

19 Mar 2010

Noscapine can be used as prophylactic treatment for prostate cancer: Study

New research has revealed a major breakthrough in the use of cough medicine ingredient noscapine as a prophylactic treatment for prostate cancer.

19 Mar 2010

FDA categorizes Nanosphere's RVNATSP assay on Verigene SP System as "Moderate Complexity"

Nanosphere, Inc., a leader in the development and commercialization of advanced molecular diagnostics systems, received notification from the U.S. Food and Drug Administration (FDA) that its respiratory virus panel (RVNATSP) performed on the Verigene SP System has been categorized as "Moderate Complexity" under the Clinical Laboratory Improvement Amendments of 1988 (CLIA).

19 Mar 2010

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

Overall mortality rates from the end of 2007 to the beginning of 2010 at Bay Medical Center in Panama City, Florida have dropped from 3.4 to 2.1. A 1.3-point drop represents a huge reduction for any hospital and translates into lives saved.

19 Mar 2010

H1N1 flu pandemic awareness helps Americans to be better prepared this year: Survey

With almost half of respondents saying they believe a sneeze travels eight feet or more, one might think you would be sick all the time. But a recent national survey of 1,017 U.S. adult men and women (age 18+) conducted by Matrixx Initiatives, Inc., maker of Zicam, found a majority of Americans polled surprisingly saw this cold and flu season as "about the same" (42%) or only "slightly worse" (21%) from last year, despite all the hype this past fall around H1N1.

19 Mar 2010

GSK's 2009 Corporate Responsibility Report published online

In its 2009 Corporate Responsibility Report published online today, GSK reiterated its commitment to running its business responsibly and to making the company more responsive, more flexible and more open to the expectations of society.

19 Mar 2010

Call for European Cystic Fibrosis healthcare gap to be closed

A healthcare gap amounting to a ‘death sentence’ for Cystic Fibrosis (CF) children born in Eastern Europe must be closed say researchers from the EuroCareCF Coordination Action for Cystic Fibrosis.

18 Mar 2010

Legacy Biotechnologies commences production of Reme-Flu

Nuvilex, Inc., announces today that Legacy Biotechnologies, Inc., its joint venture partner in Reme-Flu™, has commenced production of Reme-Flu™ and expects it to be ready for consumer purchase within the next 30 days. Reme-Flu™ is Legacy Biotechnologies’ unique 2-part homeopathic flu remedy designed to help treat symptoms of the flu. Initially, Reme-Flu™ will be offered on the top-rated website, www.nutralegacy.com.

18 Mar 2010

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children’s Hospital Boston. PATH and Genocea retain certain co-exclusive rights to the antigens for use in developing countries under their collaboration agreements with Children's Hospital Boston.

18 Mar 2010

Meta-study: Seven health risks impair academic performance of urban minority youth

"Educationally relevant health disparities" are key drivers of the achievement gap, "but they are largely overlooked," Charles Basch, the Richard March Hoe Professor of Health Education at Teachers College, Columbia University, said at a recent panel discussion at the College.

18 Mar 2010

MR-guided ablation therapy may hold promise for treatment of prostate cancer recurrences

The first known patient cases using magnetic resonance-guided heat (laser interstitial thermal therapy) or cold (cryoablation) to treat prostate cancer recurrence after surgical removal of the prostate gland were presented by physicians at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa. Many of these patients have also failed salvage radiation treatment and are often presented with limited therapeutic options. MR-guided focal therapy offers a new treatment choice for patients because of the improved detection of early prostate cancer recurrences best seen with MR imaging.

18 Mar 2010

Modulating body's inflammatory response may help fight serious infection

Treating virulent influenza, sepsis, and other potentially deadly infections long has focused on looking for ways to kill viruses and bacteria. But new research from the University of Utah and Utah State University shows that modulating the body's own overeager inflammatory response to infection may help save more lives.

18 Mar 2010

Tips to avoid exercise-related injuries in baby boomers

The March issue of Mayo Clinic Women's HealthSource covers what's behind boomeritis. Baby boomers, now in their 50s and 60s, are fitter and more athletic longer into their lives, compared with their parents' generation.

18 Mar 2010

AARP opposes passage of ‘Freedom of Conscience’ bill

Idahoans may soon learn someone else's "conscience" at the worst possible time. Today, after two days of heated debate, the Idaho House passed the Freedom of Conscience bill (SB 1353), which allows all health care professionals, including dieticians, nurses and pharmacists, to walk away from any end-of-life care that violates their conscience.

18 Mar 2010

Cryotherapy may become the future treatment for cancer

Cryotherapy, an interventional radiology treatment to freeze cancer tumors, may become the treatment of the future for cancer that has metastasized in soft tissues (such as ovarian cancer) and in bone tumors.

18 Mar 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Pressure BioSciences announces presentations on advantages of PCT

Activeion Cleaning Solutions announces new European subsidiary, Activeion GmbH

Propeller tears right arm, UT Southwestern Medical Center surgeon re-attaches

CHMP issues positive opinion recommending approval of Tarceva as monotherapy for NSCLC

Genes role in protecting intestinal tract from colitis may lead to potential targets for treatment

Implementation of evidenced-based practices reduces all healthcare-associated MRSA infections

Noscapine can be used as prophylactic treatment for prostate cancer: Study

FDA categorizes Nanosphere's RVNATSP assay on Verigene SP System as "Moderate Complexity"

Overall mortality rates at Bay Medical Center in Panama City drop 1.3 points

H1N1 flu pandemic awareness helps Americans to be better prepared this year: Survey

GSK's 2009 Corporate Responsibility Report published online

Call for European Cystic Fibrosis healthcare gap to be closed

Legacy Biotechnologies commences production of Reme-Flu

Genocea Biosciences acquires global license for novel Streptococcus pneumoniae antigens from Children’s Hospital Boston

Meta-study: Seven health risks impair academic performance of urban minority youth

MR-guided ablation therapy may hold promise for treatment of prostate cancer recurrences

Modulating body's inflammatory response may help fight serious infection

Tips to avoid exercise-related injuries in baby boomers

AARP opposes passage of ‘Freedom of Conscience’ bill

Cryotherapy may become the future treatment for cancer

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Redefining control and consistency in anaerobic microbiome workflows

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Redefining control and consistency in anaerobic microbiome workflows

Newsletters you may be interested in